Professor Kim Tae-hee of the Department of Obstetrics and Gynecology at Soonchunhyang University Bucheon Hospital participated as an invited speaker at the '5th International Obstetrics and Gynecology Conference' held at City Seasons Suites Hotel in Dubai, UAE, from the 3rd to the 4th, where she presented the latest clinical results.

As global interest in stem cell-based regenerative medicine grows, Professor Kim received significant attention for her presentation on the topic 'Intravenous Injection of Autologous Blood Concentrate Including Hematopoietic Stem Cells Enhances NK Cell Activity in Female Patients: A Retrospective Observational Study.'

Professor Kim stated, "This study focused on the immune response and therapeutic effects in female patients treated for aging-related and chronic diseases," adding, "The administration of growth factors, including hematopoietic stem cells, demonstrated distinct potential in immune modulation and regenerative effects."

She further explained, "We evaluated how the administration of cells, including CD34+ stem cells, affects changes in NK cell activity and the improvement trend of blood biomarkers across different age groups of female patients," noting that "the study was conducted on 44 women with an average age of 56 (±13 years), with the main therapeutic goals being the alleviation of menopausal symptoms, anti-aging, chronic fatigue, skin diseases, joint pain, cancer history, diabetes, and cardiovascular disease improvement."

Professor Kim continued, "The treatment formulation involved using the Miracell SmartMCell system and BSC kit to centrifuge and concentrate nucleated cells and platelets from whole blood for intravenous administration," and "the measurement of NK cell activity before and after treatment using the IFN-γ (interferon-gamma) release assay showed a significant increase from an average of 504.9pg/ml before treatment to 783.9pg/ml after treatment."

In particular, she added, "In the patient group with pre-treatment NK cell activity below 100pg/ml (average 56.9pg/ml), there was an approximately 10.7-fold increase to an average of 609.3pg/ml after treatment, with a general trend of improvement in NK cell activity across all age groups."

Professor Kim concluded, "The significant enhancement of NK cell-mediated immune activation through hematopoietic stem cells suggests the potential to improve the quality of life for women experiencing early menopause and aging-related chronic diseases," and expressed plans to continue clinical research to enhance the global competitiveness of K-regenerative medicine in the future."

Popular News